Datasets:

electricsheepafrica
/

africa-synth-tuberculosis-anti-tb-medicine-quality-all

record_id string	scenario string	year int64	setting string	age int64	sex string	hiv_coinfected int64	treatment_phase string	drug string	manufacturer string	gdf_procured int64	is_substandard_falsified int64	is_falsified int64	api_pct_label float64	api_failure int64	dissolution_failure int64	rifampicin_degraded int64	storage_poor int64	treatment_failure int64	sputum_conversion_delayed int64	mdr_emergence int64	death int64	hepatotoxicity int64	dots_observed int64	treatment_completed int64	lost_to_followup int64	quality_tested int64	genexpert_done int64	any_adverse int64
DOT-00000	dots_program_public	2,022	district_hospital	45	female	1	continuation	isoniazid	local_generic	1	0	0	100.5	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0
DOT-00001	dots_program_public	2,022	health_centre	32	male	0	continuation	isoniazid	who_prequalified	1	1	1	22.8	1	0	0	0	0	0	0	0	0	0	1	0	0	1	0
DOT-00002	dots_program_public	2,020	district_hospital	42	female	0	intensive	RHZE_FDC	indian_generic	1	0	0	97.3	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0
DOT-00003	dots_program_public	2,012	health_centre	48	female	0	continuation	rifampicin	indian_generic	1	1	0	77.9	1	0	0	1	0	0	0	0	0	0	1	0	0	0	0
DOT-00004	dots_program_public	2,022	TB_clinic	29	male	0	continuation	RHZE_FDC	indian_generic	1	0	0	99.7	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0
DOT-00005	dots_program_public	2,021	TB_clinic	53	female	0	intensive	RHZE_FDC	who_prequalified	0	0	0	90.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
DOT-00006	dots_program_public	2,019	health_centre	20	male	1	continuation	RHZE_FDC	who_prequalified	1	0	0	94.4	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0
DOT-00007	dots_program_public	2,022	TB_clinic	62	male	0	continuation	RH_FDC	gdf_procured	1	0	0	94.6	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0
DOT-00008	dots_program_public	2,021	health_centre	48	female	1	intensive	rifampicin	gdf_procured	0	0	0	93.4	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0
DOT-00009	dots_program_public	2,017	community_dots	37	female	0	continuation	RH_FDC	gdf_procured	0	0	0	101.4	0	0	0	1	0	0	0	0	0	1	1	0	0	1	0
DOT-00010	dots_program_public	2,019	community_dots	54	male	0	continuation	RH_FDC	who_prequalified	1	0	0	97.4	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0
DOT-00011	dots_program_public	2,021	TB_clinic	28	male	0	continuation	other	gdf_procured	0	1	0	67.6	1	1	0	1	0	0	0	0	0	0	1	0	1	1	0
DOT-00012	dots_program_public	2,022	TB_clinic	32	female	0	continuation	RH_FDC	gdf_procured	1	0	0	90	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
DOT-00013	dots_program_public	2,012	community_dots	21	male	0	intensive	RHZE_FDC	who_prequalified	1	1	1	19.2	1	1	0	0	0	0	0	0	0	0	1	0	0	1	0
DOT-00014	dots_program_public	2,019	district_hospital	24	male	0	intensive	ethambutol	who_prequalified	0	1	0	71.8	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0
DOT-00015	dots_program_public	2,017	district_hospital	37	male	1	continuation	RH_FDC	gdf_procured	1	0	0	95.7	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0
DOT-00016	dots_program_public	2,018	community_dots	41	female	0	continuation	RHZE_FDC	local_generic	1	0	0	96.2	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0
DOT-00017	dots_program_public	2,019	health_centre	25	female	1	continuation	RHZE_FDC	indian_generic	1	0	0	99.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
DOT-00018	dots_program_public	2,012	TB_clinic	55	female	0	continuation	rifampicin	gdf_procured	0	0	0	98.1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0
DOT-00019	dots_program_public	2,019	community_dots	37	male	0	continuation	isoniazid	unknown	1	0	0	96.2	0	0	0	1	0	0	0	0	0	0	1	0	0	1	1
DOT-00020	dots_program_public	2,023	health_centre	15	female	0	intensive	ethambutol	who_prequalified	0	0	0	97.6	0	0	0	1	1	1	0	0	0	0	0	0	0	1	1
DOT-00021	dots_program_public	2,010	health_centre	16	male	0	intensive	ethambutol	unknown	0	0	0	102.3	0	0	0	1	0	0	0	0	0	0	1	0	0	1	0
DOT-00022	dots_program_public	2,021	TB_clinic	29	female	0	continuation	RHZE_FDC	indian_generic	1	0	0	89.7	0	0	0	1	0	0	0	0	0	1	0	0	0	1	0
DOT-00023	dots_program_public	2,024	district_hospital	14	female	0	continuation	RHZE_FDC	indian_generic	1	0	0	105.3	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0
DOT-00024	dots_program_public	2,013	health_centre	19	male	0	continuation	RHZE_FDC	indian_generic	0	0	0	95.9	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0
DOT-00025	dots_program_public	2,018	health_centre	36	female	0	continuation	isoniazid	gdf_procured	0	0	0	99.4	0	0	0	1	1	1	0	0	0	0	0	0	1	0	1
DOT-00026	dots_program_public	2,016	TB_clinic	24	male	0	continuation	other	local_generic	1	0	0	90.8	0	0	0	0	0	0	0	0	0	1	1	0	0	0	1
DOT-00027	dots_program_public	2,024	health_centre	22	female	1	intensive	RH_FDC	who_prequalified	0	0	0	103.3	0	0	0	1	0	0	0	0	0	0	1	0	0	0	1
DOT-00028	dots_program_public	2,018	TB_clinic	11	female	0	continuation	rifampicin	local_generic	1	0	0	99.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
DOT-00029	dots_program_public	2,023	district_hospital	22	male	0	continuation	RHZE_FDC	gdf_procured	1	1	0	73.2	1	1	0	1	0	0	0	0	0	0	1	0	0	0	0
DOT-00030	dots_program_public	2,024	health_centre	19	male	0	intensive	rifampicin	indian_generic	0	0	0	98	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0
DOT-00031	dots_program_public	2,024	district_hospital	10	male	0	intensive	rifampicin	local_generic	0	0	0	98.8	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1
DOT-00032	dots_program_public	2,014	health_centre	28	male	0	continuation	RHZE_FDC	indian_generic	0	0	0	92.8	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0
DOT-00033	dots_program_public	2,023	TB_clinic	43	male	0	continuation	other	gdf_procured	1	0	0	99.5	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0
DOT-00034	dots_program_public	2,011	TB_clinic	39	male	0	intensive	RH_FDC	unknown	0	0	0	95.6	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0
DOT-00035	dots_program_public	2,015	TB_clinic	46	male	0	intensive	rifampicin	local_generic	0	0	0	99.5	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0
DOT-00036	dots_program_public	2,020	community_dots	39	male	1	continuation	RHZE_FDC	who_prequalified	1	1	0	62	1	1	1	0	1	0	0	0	0	1	0	0	0	1	1
DOT-00037	dots_program_public	2,018	district_hospital	44	female	0	intensive	RHZE_FDC	gdf_procured	1	0	0	102.8	0	0	0	0	0	0	0	0	0	0	1	0	1	1	1
DOT-00038	dots_program_public	2,023	TB_clinic	45	male	1	continuation	RHZE_FDC	indian_generic	0	0	0	97.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
DOT-00039	dots_program_public	2,019	community_dots	50	female	0	continuation	rifampicin	gdf_procured	1	0	0	99.5	0	0	0	1	1	1	0	0	0	1	0	0	0	1	1
DOT-00040	dots_program_public	2,021	TB_clinic	35	female	1	intensive	other	indian_generic	1	0	0	97.2	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0
DOT-00041	dots_program_public	2,010	health_centre	49	female	1	continuation	rifampicin	gdf_procured	0	0	0	101.4	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0
DOT-00042	dots_program_public	2,016	TB_clinic	39	male	0	intensive	other	who_prequalified	1	0	0	98.3	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0
DOT-00043	dots_program_public	2,019	TB_clinic	29	female	0	intensive	RHZE_FDC	local_generic	1	0	0	97.1	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0
DOT-00044	dots_program_public	2,024	district_hospital	47	male	0	intensive	RHZE_FDC	indian_generic	1	0	0	93.1	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0
DOT-00045	dots_program_public	2,014	TB_clinic	20	female	0	continuation	RHZE_FDC	gdf_procured	1	0	0	96.9	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0
DOT-00046	dots_program_public	2,011	community_dots	23	male	1	intensive	RHZE_FDC	unknown	0	0	0	98.9	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0
DOT-00047	dots_program_public	2,011	TB_clinic	19	male	0	intensive	RHZE_FDC	local_generic	0	0	0	93.1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0
DOT-00048	dots_program_public	2,018	district_hospital	40	male	1	intensive	other	indian_generic	0	0	0	99.4	0	0	0	1	1	1	0	0	0	0	0	0	0	0	1
DOT-00049	dots_program_public	2,024	community_dots	5	male	1	continuation	RHZE_FDC	who_prequalified	1	0	0	106	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0
DOT-00050	dots_program_public	2,014	TB_clinic	47	male	1	continuation	RH_FDC	unknown	1	0	0	101.4	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0
DOT-00051	dots_program_public	2,010	district_hospital	39	female	0	continuation	rifampicin	gdf_procured	0	0	0	102.3	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0
DOT-00052	dots_program_public	2,015	district_hospital	43	male	1	continuation	rifampicin	indian_generic	1	0	0	102.8	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0
DOT-00053	dots_program_public	2,015	health_centre	39	male	0	continuation	other	indian_generic	1	0	0	101.2	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0
DOT-00054	dots_program_public	2,017	community_dots	44	male	0	continuation	rifampicin	gdf_procured	1	0	0	99.2	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0
DOT-00055	dots_program_public	2,020	TB_clinic	36	female	0	intensive	ethambutol	unknown	1	1	0	71.8	1	0	0	1	1	1	0	0	0	0	0	0	0	1	1
DOT-00056	dots_program_public	2,022	TB_clinic	36	female	1	continuation	RHZE_FDC	indian_generic	0	0	0	100.2	0	0	0	0	0	0	0	0	0	1	1	0	0	1	0
DOT-00057	dots_program_public	2,017	district_hospital	43	female	0	continuation	ethambutol	local_generic	1	0	0	102.9	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0
DOT-00058	dots_program_public	2,018	TB_clinic	41	male	0	continuation	RHZE_FDC	indian_generic	0	0	0	96	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0
DOT-00059	dots_program_public	2,021	district_hospital	35	male	0	intensive	RHZE_FDC	local_generic	1	1	1	33.3	1	0	1	1	0	0	0	0	0	0	0	0	0	1	0
DOT-00060	dots_program_public	2,020	TB_clinic	13	female	0	continuation	isoniazid	who_prequalified	1	0	0	89.4	0	0	0	1	0	0	0	0	0	1	1	0	0	1	0
DOT-00061	dots_program_public	2,019	health_centre	43	male	1	continuation	rifampicin	who_prequalified	0	0	0	101	0	0	0	0	1	1	0	0	0	0	0	0	0	1	1
DOT-00062	dots_program_public	2,013	TB_clinic	25	male	0	intensive	RH_FDC	gdf_procured	0	0	0	96.3	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0
DOT-00063	dots_program_public	2,022	district_hospital	45	male	0	intensive	streptomycin	indian_generic	0	0	0	92.5	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0
DOT-00064	dots_program_public	2,015	TB_clinic	56	female	0	intensive	RH_FDC	indian_generic	0	0	0	89.8	0	0	0	0	0	0	0	0	0	1	1	0	0	1	0
DOT-00065	dots_program_public	2,015	district_hospital	59	male	0	intensive	RHZE_FDC	indian_generic	0	0	0	93.7	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0
DOT-00066	dots_program_public	2,019	TB_clinic	26	female	0	intensive	isoniazid	unknown	1	0	0	97.2	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0
DOT-00067	dots_program_public	2,018	district_hospital	46	female	0	intensive	rifampicin	unknown	1	1	0	76.3	1	0	0	0	0	0	0	0	0	0	1	0	0	1	0
DOT-00068	dots_program_public	2,015	community_dots	32	male	0	continuation	RHZE_FDC	indian_generic	1	0	0	97.9	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0
DOT-00069	dots_program_public	2,016	community_dots	61	male	0	continuation	rifampicin	indian_generic	1	1	0	49.5	1	0	1	0	0	0	0	0	0	0	1	1	0	1	1
DOT-00070	dots_program_public	2,018	community_dots	29	male	0	intensive	other	gdf_procured	1	0	0	92.5	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0
DOT-00071	dots_program_public	2,018	district_hospital	39	female	0	continuation	RH_FDC	gdf_procured	1	0	0	102	0	0	0	1	0	0	0	0	0	0	1	1	0	1	0
DOT-00072	dots_program_public	2,024	TB_clinic	32	female	0	intensive	RHZE_FDC	who_prequalified	1	0	0	99.8	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0
DOT-00073	dots_program_public	2,016	TB_clinic	66	male	0	intensive	isoniazid	indian_generic	1	0	0	97.7	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0
DOT-00074	dots_program_public	2,018	district_hospital	33	male	0	continuation	RH_FDC	indian_generic	1	0	0	102.8	0	0	0	0	1	0	0	0	0	0	0	1	0	0	1
DOT-00075	dots_program_public	2,017	health_centre	67	female	0	continuation	rifampicin	unknown	1	0	0	101	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0
DOT-00076	dots_program_public	2,020	health_centre	32	male	1	continuation	RHZE_FDC	who_prequalified	1	0	0	97.5	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0
DOT-00077	dots_program_public	2,015	TB_clinic	26	female	1	continuation	isoniazid	local_generic	0	0	0	94.7	0	0	0	1	0	0	0	0	0	1	1	0	0	1	0
DOT-00078	dots_program_public	2,012	district_hospital	47	male	1	continuation	streptomycin	indian_generic	0	0	0	91.9	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0
DOT-00079	dots_program_public	2,017	district_hospital	42	female	0	continuation	RHZE_FDC	gdf_procured	0	0	0	93.3	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0
DOT-00080	dots_program_public	2,015	health_centre	42	male	1	intensive	streptomycin	indian_generic	0	0	0	94.1	0	0	0	1	0	0	0	0	0	0	1	0	0	1	0
DOT-00081	dots_program_public	2,014	community_dots	37	male	0	intensive	isoniazid	local_generic	1	0	0	92	0	0	0	1	0	0	0	0	1	1	0	1	0	0	1
DOT-00082	dots_program_public	2,016	TB_clinic	21	male	0	continuation	rifampicin	indian_generic	0	0	0	98.3	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0
DOT-00083	dots_program_public	2,017	TB_clinic	37	female	0	intensive	RHZE_FDC	gdf_procured	1	0	0	99.1	0	0	0	1	0	0	0	0	1	0	0	0	0	0	1
DOT-00084	dots_program_public	2,023	TB_clinic	40	female	0	continuation	isoniazid	who_prequalified	0	0	0	89.9	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0
DOT-00085	dots_program_public	2,014	district_hospital	33	female	0	continuation	streptomycin	gdf_procured	0	0	0	96.1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0
DOT-00086	dots_program_public	2,017	community_dots	25	male	0	intensive	isoniazid	gdf_procured	0	0	0	98.8	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0
DOT-00087	dots_program_public	2,019	district_hospital	26	male	0	intensive	RH_FDC	unknown	1	0	0	96.4	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0
DOT-00088	dots_program_public	2,014	TB_clinic	19	female	0	continuation	RH_FDC	indian_generic	1	0	0	101.1	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0
DOT-00089	dots_program_public	2,015	TB_clinic	16	male	1	intensive	other	who_prequalified	1	0	0	94.9	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0
DOT-00090	dots_program_public	2,017	TB_clinic	23	male	1	intensive	ethambutol	gdf_procured	0	0	0	94.7	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0
DOT-00091	dots_program_public	2,019	health_centre	66	female	1	continuation	rifampicin	indian_generic	1	0	0	96.4	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0
DOT-00092	dots_program_public	2,017	district_hospital	50	female	0	continuation	rifampicin	local_generic	1	0	0	87.3	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0
DOT-00093	dots_program_public	2,011	TB_clinic	38	female	0	intensive	rifampicin	who_prequalified	0	0	0	96.8	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0
DOT-00094	dots_program_public	2,023	community_dots	7	male	1	intensive	rifampicin	unknown	0	0	0	96	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0
DOT-00095	dots_program_public	2,024	community_dots	45	male	0	continuation	rifampicin	indian_generic	0	0	0	102.9	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0
DOT-00096	dots_program_public	2,019	TB_clinic	44	male	0	intensive	RHZE_FDC	who_prequalified	0	1	0	70.9	1	0	0	1	0	0	1	0	0	0	1	0	0	0	1
DOT-00097	dots_program_public	2,021	health_centre	20	male	0	continuation	RH_FDC	gdf_procured	1	0	0	95.2	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0
DOT-00098	dots_program_public	2,017	health_centre	5	male	1	continuation	RH_FDC	who_prequalified	0	0	0	101.3	0	0	0	0	1	0	0	1	0	0	0	0	0	0	1
DOT-00099	dots_program_public	2,011	community_dots	51	female	0	continuation	RHZE_FDC	local_generic	1	0	0	89.3	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0

End of preview. Expand in Data Studio

⚠️ Synthetic dataset — Parameterized from published SSA literature, not real observations. Not suitable for empirical analysis or policy inference.

Anti-TB Medicine Quality in Sub-Saharan Africa

Abstract

Synthetic dataset modelling anti-TB medicine quality, rifampicin degradation, treatment outcomes, and MDR-TB emergence across DOTS programs, MDR-TB units, and informal markets in SSA. ~70% of quality reports detected falsified/substandard TB medicines; substandard rifampicin drives treatment failure and MDR-TB.

Parameterization Evidence

Parameter	Value	Source	Year
~70% reports detected SF TB/HIV medicines	Prevalence	IntechOpen	2024
Rifampicin most commonly SF anti-TB drug	Quality	WHO/Lancet ID	2020
SF rifampicin → treatment failure, MDR-TB	Resistance	Literature	2022
GDF procurement improves quality assurance	Supply	Stop TB Partnership	2023

Validation

Usage

from datasets import load_dataset
ds = load_dataset("electricsheepafrica/anti-tb-medicine-quality", "dots_program_public")

References

IntechOpen. Medicines quality in LMICs. 2024.
WHO. TB drug quality and DOTS programmes. 2020.
Stop TB Partnership/GDF. Quality-assured TB medicines. 2023.

Citation

@dataset{electricsheepafrica_anti_tb_medicine_quality_2025,
  title={Anti-TB Medicine Quality in Sub-Saharan Africa},
  author={Electric Sheep Africa},
  year={2025},
  publisher={HuggingFace},
  url={https://huggingface.co/datasets/electricsheepafrica/anti-tb-medicine-quality}
}

License

CC-BY-4.0

Downloads last month: 52